ELLANSÉ® vs Hyaluronic Acid Fillers

Ellansé has been shown to help stimulate and regenerate collagen in the skin. This natural increase in collagen production is key to the longevity of Ellansé and provides long-term benefits. Ellansé can be found in four variations, lasting up to four years*.

Ellansé offers dual action for reducing the signs of ageing; long-term regeneration of collagen as well as immediate effects of volume and facial contouring, for the correction of wrinkles, folds, sagging and loss of definition.**

What is Collagen?

Collagen is a structural protein present throughout the body, including the skin. Collagen helps provide the structure and strength, by providing integrity, firmness and elasticity. As we age, collagen production and content in the skin reduces, causing the skin to sag and lose elasticity. Also, without these key structural proteins to support the skin, lines and wrinkles begin to appear and grow with time.

Hyaluronic Acid Fillers

Hyaluronic acid is naturally present in the skin however production is naturally reduced with ageing. Hyaluronic acid fillers are injected to generate volume, and to fill fine lines and wrinkles. Hyaluronic acid fillers tend to be the most temporary option, and therefore are often recommended for first time filler patients. These will typically last from 6 to 18 months1.

The Conclusion

When comparing Ellansé with hyaluronic acid, Ellansé offers several advantages in terms of both longevity and efficiency. Results show that less Ellansé volume needs to be injected to reach the optimal effect2. These attributes associated with polycaprolactone, overall results in lower chances for ‘over-filling’ with Ellansé and longer-lasting and more natural looking results.

Depending on your individual needs and desired results, it is best to consult with your physician before choosing your treatment.

*Expected longevity in-vivo based on extrapolation of clinical data from –S and –M accepted PCL degradation behaviour.

** Ellansé is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions, or for subdermal implantation in the dorsal superficial lamina of the hands, for hands rejuvenation.

2Galadari H, et al. A randomised, prospective, blinded, split-face, single-centre study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. J Cosmet Dermatol. 2015;14(1):27-32

Share this post:

Sinclair Network

At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.

Sinclair Pharma News

Aesthetic Awards 2019

The Aesthetic Awards 2019 were hosted on the 7th of December at them Park Plaza Westminster Bridge hotel in London. Sinclair Pharma UK...

Industry News